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The effect of aminolaevulinic acid-induced, protoporphyrin TX-mediated
photodynamic therapy on the cremaster muscle microcirculation in vivo
J Leveckis, NJ Brown, MWR Reed
Department of Surgical and Anaesthetic Sciences, Lniversity of Sheffield, Roval Hallamshire Hospital, Glossop Road, Sheffield,
510 2JF, UK.
Summary The effect of photodynamic therapy on normal striated muscle was investigated using 30 adult
male rats. Animals were divided into six groups. Three control groups received phosphate-buffered saline by
gavage and violet light at 105. 178 and 300 mW cm -' respectively. Three experimental groups received
aminolaevulinic acid (ALA: 200mg kg -') and violet hght at 105. 178 and 300 mW cm-- respectively. After
exposure of the cremaster muscle animals were allowed to equilibrate and vessel diameters and bloodflow
assessed. Following photoactivation measurements were taken every 10 min over a 2 h penrod. Photoactivation
of expenrmental groups at the two higher power densities resulted in an initial decrease in both artenrolar and
venular diameters, and a concomitant decrease in blood flow. The magnitude of these changes and the degree
of recovery by the end of the observation period was related to power density. No effects were observed in the
control groups. These results suggest that microcirculatory damage may contribute to the mechanism of action
of photodynamic therapy with ALA.
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Photodynamic therapy (PDT) is an experimental treatment
for cancer in which cell death occurs as a result of the
interaction of light with a photosensitising drug. PDT using
the photosensitiser haematoporphyrin derivative (HPD) has
been shown to be effective in the treatment of cancers in
various sites including skin (Dougherty, 1987), bronchus
(Balchum, 1984) and bladder (Nseyo, 1992), often after more
conventional treatments have failed. The cytoxicity of HPD-
mediated PDT has been attributed to the production of
reactive oxygen species, although the precise mechanism of
damage is not clear. Injury to cell membranes and subcellular
structures has been demonstrated in vitro and in vivo but this
damage appears to be sublethal and does not fully explain
the tissue destruction observed following PDT (Henderson et
al., 1985). A significant role for the microcirculation as a
target for PDT has been proposed and disruption of blood
flow in normal tissues and tumours after HPD-mediated
PDT described (Star et al., 1986; Wieman et al., 1988).
Aminolaevulinic acid (ALA) is a naturally occurring
precursor of the photosensitising agent protoporphyrin IX
(PpIX) (Elder, 1983). Owing to the relatively slow conversion
of PpIX into haem (Pottier et al., 1986), the addition of large
quantities of exogenous ALA results in the accumulation of
photosensitising amounts of PpIX in many tissues (Pottier et
al., 1986; Kennedy et al., 1990; Loh et al., 1993; Leveckis et
al., 1994). A photodynamic effect may be achieved by the
exposure of tissues to light, which correlates with the inten-
sity of PpIX fluorescence on microscopy (Divans et al.,
1990). Preliminary clinical studies have shown ALA to be an
effective photosensitising agent (Kennedy et al., 1990; Wolf et
al., 1993). It has significant potential advantages over HPD
due to its low toxicity, short period of skin sensitisation and
absorption after topical application (Berlin et al., 1956a,b;
Kennedy et al., 1990). In contrast to the current photosensit-
isers in clinical and experimental use, ALA-induced PpIX
appears to localise in cells, rather than the stroma or blood
vessels of both normal and tumour tissue (Bedwell et al.,
1992). On the basis of these findings it has been suggested by
some authors that ALA-induced, PpIX-mediated PDT may
act predominantly by a different mechanism to that of HPD,
with direct cytotoxicity being of more significance than
microcirculatory damage (Loh et al., 1992).
The aim of this study is to determine whether ALA-
induced, PpIX-mediated PDT has an effect on the micro-
circulation. The model used was the rat cremaster prepara-
tion (Baez, 1973; Meininger et al., 1987), a thin sheet of
somatic muscle in which the microvasculature can be studied
by in vivo microscopy. The rat cremaster preparation has
been used extensively in the field of microcirculatory
research, including study of the effect of PDT on the micro-
circulation (Reed et al., 1988).
Materias and methods
Animals and ALA administration
Experiments were performed on male adult Wistar rats
(n = 30) weighing 100 g, obtained from the University of
Sheffield Field Laboratories. ALA for oral administration
was prepared by dissolving in phosphate-buffered saline
(PBS) (Sigma, Poole, Dorset, UK) resulting in a solution of
pH 2.8. Three treatment groups of five animals (groups I, II
and V) received ALA (200mg kg-1) in a volume of up to
1 ml PBS by gavage using 3 mm diameter soft silicone tub-
ing. Precise dosing based on animal weight (± 10 g) was
achieved by varying the volume administered to each animal.
Three control groups of five animals (groups III, IV and VI)
received 1 ml of PBS by gavage. In all groups, dosing was
carried out 4 h before photoactivation. During the period
between dosing and preparation for in vivo microscopy,
animals were returned to their cages and allowed free access
to both food ('Rodent pellets', Argo Feeds, Stannington,
South Yorkshire, UK) and water.
Preparation for in vivo microscopy
One hour before photoactivation animals were anaesthetised
by subcutaneous injection of a mixture of Hypnorm (Janssen
Pharmaceutical) 0.5 ml kg-' (fentanyl citrate 0.315 mg ml-',
fluanisone 10mg ml-') and diazemuls (Dumex) 0.5 ml kg'
(5 mg ml'-), 1:1 (v/v).
The left carotid artery was cannulated and connected to a
pressure transducer and physiograph (Micro-Med, Louisville,
USA) which monitored mean arterial blood pressure and
heart rate. An oesophageal thermistor probe was inserted
and connected to a digital thermometer (Fluke, Washington,
USA). The animal was placed on a warming pad on a
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Perspex animal board in order to maintain body temperature
(35-37C) during photoactivation and the recovery phase.
The right side of the scrotum was opened in the ventral
midline and the testis and surrounding cremaster gently
dissected from adjacent connective tissue. A 3 0 silk stay
suture was placed in the apex of the cremaster. which was
then positioned on a glass microscope slide mounted on
perspex pegs attached to the animal board. The muscle was
held in place by the stay suture and electrocautery used to
open the cremaster along the avascular plane in the ventral
midline, with care taken to avoid damage to the underlying
testis. Four more stay sutures were positioned around the
circumference of the cremaster to open the preparation. The
dorsal connective tissue ligament between the testis and the
cremaster was divided using cautery and the testis gently
returned to the abdominal cavity. The cremaster muscle
preparation with intact neurovascular supply was moistened
with physiological saline and covered with an impermeable
membrane (Saran wrap, Dow Brands, Indianapolis, IN,
USA) to prevent dehydration during the period of observa-
tion.
Experimental protocol: photoactivation, data collection and
image anal! sis
The animal. warming pad and perspex board were transfer-
red to the stage of a microscope equipped with a tungsten
lamp for transmitted light microscopy and a 100 W mercury
arc lamp for epi-illumination (Leitz. Germany). After trans-
fer a further thermistor was placed under the edge of the
cremaster and connected to the second channel of the ther-
mometer. Animals were allowed an equilibration period of
30 min before photoactivation. During this time the prepara-
tion was briefly scanned with low-level transmitted light and
a suitable 'area of interest' (AOI) containing second order
arterioles and venules selected for study.
During each period of observation of the AOI. images of
the preparation were obtained via a x 10 lens. using a
charged-coupled device (CCD) camera (model KP-161.
Hitachi, Japan). displayed on a high-resolution monitor
(Sony PVM-1443) and recorded on video (Sony SLV-373-
UB) for later off-line analysis. At the end of the equilibration
period the AOI was observed for 30s to obtain baseline
values for vessel diameters. A bandpass filter interposed into
the light path of the mercury arc lamp permitted violet
(390-460 nm) light to be selected for epi-illumination and
photoactivation. using the major absorbance peak of PpIX
(405 nm). The power output was determined immediately
before activation and at the end of each experiment using an
optometer. Treatment times were altered as necessary after
measuring the power output. to achieve a constant energy
density of 100 J cm- in all groups. The power output of the
system as described was 16 mW: in order to achieve the
lower power densities required, 5% and 30% neutral density
filters were interposed between the light source and objective
lens.
All groups received violet light to the AOI at a constant
energy density of 100 J cm- but at three different rates of
delivery (power densities). Animals in groups I and III
received 105 mWcmrn, groups II and IV 178 mWcm-2, and
groups V and VI 300 mW cm-. During photoactivation
images were recorded continuously using low-level trans-
mitted light. After photoactivation further recordings of the
area of interest were taken for 30 s at 10 min intervals for
2 h. Qualitative changes in blood flow were noted and
quantitative changes in vessel diameters measured using
computerised image analysis software (Image Pro Plus.
Media Cybernetics, USA) preloaded on an IBM-compatible
PC (Vig IV 25. Viglen, London. UK). calibrated to produce
direct measurements in micrometres. The parameter meas-
ured to record vessel diameter was the red blood cell column
diameter (RBCCD). Recordings of RBCCD were made every
minute during photoactivation and every 10mmn thereafter.
The ALA and light dose groups are summarised in Table I.
Statistical analysis
Since vessel diameters between animals varied. results are
expressed in terms of percentage change in diameter com-
pared to the prephotoactivation diameter (by definition
100%). Differences in vessel diameter between control and
treatment groups and between prephotoactivation vessel
diameter and diameter during photoactivation and the
recovery phase were compared using the Mann -Whitney
U-test for non-parametric data. Differences were considered
significant at P< 0.05.
Results
Arteriolar response to ALA-induced. PpIX-mediated PDT
No significant change in vessel diameter was observed in the
ALA-treated animals during or after photoactivation with
violet light at 105 mW cm- (Figure la).
At 178 mW cm-' a rapid reduction in vessel diameter was
observed in the ALA-treated group. which reached
significance 4 mmn into the period of photoactivation
(P <0.02). The maximum decrease in vessel diameter (to
22.8% of pretreatment diameter) occurred by the end of
photoactivation. During the recovery phase there was a
gradual increase in vessel diameter in the ALA-treated group,
which at 2 h was not significantly different from the pretreat-
ment value (Figure lb).
At 300 mW cm-2 a rapid decrease in vessel diameter was
observed in the ALA-treated group, which reached
significance 2 mmn into the period of photoactivation
(P< 0.02). The maximum decrease in vessel diameter (to
18% of pretreatment diameter) occurred by the end of
photoactivation. During the recovery phase there was a
gradual increase in vessel diameter in the ALA-treated group.
which by 70 min was not significantly different from the
pretreatment value (Figure lc).
No significant change in vessel diameters was observed in
the three control groups receiving light but no ALA.
Venular response to ALA-induced, PpIX-mediated PDT
There was no significant change in vessel diameter in the
ALA-treated group during photoactivation with violet light
at 105 mW cm- A small but significant reduction in vessel
diameter (to 91.8% of pretreatment diameter), lasting 40 min
Table I Treatment groups: ALA dose. light dose, and photoactivation time
Groups
I II III If" V [I
ALA 200 200 - - 200 -
(mg kg- ')
Fluorescent light 105 178 105 178 300 300
(mW cm -2)
Transmitted light + + + + + +
Treatment time 17.4 9.4 17.4 9.4 5.5 5.5
(min)
was observed in the ALA-treated group 20 min after the end
of photoactivation (P <0.02). At the end of the recovery
period vessel diameters returned to their pretreatment values
(Figure 2a).
There was no significant change in vessel diameter in the
ALA-treated group during photoactivation with violet light
at 178 mW cm- A reduction in vessel diameter however
occurred during the early part of the recovery phase in the
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ALA-treated group, reaching a minimum of 74% of pretreat-
ment diameter 20 min after the end of photoactivation
(P <0.02). The reduction was maintained for 40 min after
photoactivation. following which vessel diameters returned to
pretreatment values (Figure 2b).
A reduction in vessel diameter was observed in the ALA-
treated group, which commenced 4 min into photoactivation
with violet light at 300 mW cm -. This reached a maximum
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Fgwe I Arteriolar response to ALA-induced. PpIX-mediated PDT. Violet light at 105 mW cm-' (a) 178 mW cm- 2 (b)
300mW cm-- (c) To = end of period of photoactivation. 0, controls; V, treated animals receiving ALA 200 mg kg-: 4 h before
photoactivation; mean ± s.e.m.. n = 5 for each value. Horizontal bar indicates period of photoactivation.
u
-10 0
C
O10
00-
0
.0
C
CD
C
CD)
80 -
60
40 !T
20-
A
NAl cdPpIX-mndiad PDT oa a mlramed. Mdc oched_am - wI
J Leveckis et a
1116
of 53% of the pretreatment value 40min after the end of
photoactivation and was maintained throughout most of the
recovery period, only returning to the pretreatment value at
110min (Figure 2c).
No significant change in vessel diameter was observed in
the three control groups either during photoactivation or the
recovery period.
Capillary andflow responses to ALA-indued, PpIX-mediated
PDT
At 105 mW cm-2 all preparations in the ALA-treated group
exhibited mild irritability during photoactivation with slow-
ing of capillary flow. During the recovery period normal
capillary flow returned in four of the five cremasters. In the
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Fuwe 2 Venular response to ALA-induced, PpIX-mediated PDT. V-iolet light at 105 mW cm-2 (a) 178 mW cm2 (b)
300mW cm-2 (c) To = end of period of photoactivation. 0, controls; V, treated animals receiving ALA 200mg kg-2 4 h before
photoactivation; mean ± s.e.m., n = 5 for each value. Horizontal bar indicates period of photoactivation.
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fifth preparation a reduction in arterial flow was observed
during treatment which was maintained to the end of the
recovery phase.
At 178 mW cm- a rapid reduction in capillary flow was
observed in all preparations in the ALA-treated group. At
the end of the recovery period complete cessation of capillary
flow was still evident in three of the five preparations, with
very sluggish return of flow in two. Arterial blood flow
reduced progressively during photoactivation, with partial
recovery only in four cases.
At 300mWcm-2 a rapid reduction in capillary flow was
observed in all preparations in the ALA-treated group, with
complete cessation of flow by the end of photoactivation. At
the end of the recovery period there was return of capillary
flow in two of the five preparations. A reduction in artenral
blood flow during photoactivation, which returned to normal
at the end of the recovery period was observed in four of the
five preparations. Venous blood flow was reduced during
photoactivation but returned to normal in all preparations by
the end of the recovery period.
No changes in blood flow were observed in the control
group.
Phisiological parameters
There were no significant differences between oesophageal
temperature. cremasteric temperature, heart rate and blood
pressure between the control and ALA-treated groups.
Discs_sh
Direct cytotoxicity has been shown to be insufficient to ex-
plain the effects of PDT. Cells from murine tumours remain-
ing in situ after PDT undergo necrosis, whereas those exp-
lanted immediately after photoactivation remain viable in
vitro, suggesting that local tissue factors may play an impor-
tant role (Henderson et al., 1985).
Blood flow changes resulting from PDT were first quant-
ified by Selman et al. (1984) in transplantable bladder
tumours treated with HPD (lIOgg-1) and red light
(630 J cm- 2). Using a radioactive microsphere technique they
demonstrated a significant reduction in blood flow to
tumours 10min and 24 h after the end of photoactivation.
Using an identical model, blood flow reduction was shown to
be related to both light and photosensitiser dose (Selman et
al., 1985a). The hypothesis that abnormal tumour vas-
culature might be responsible for the selectivity of PDT was
challenged when Selman's group also reported similar blood
flow changes in non-neoplastic tissue (Selman et al., 1985b).
Though the radioactive microsphere technique and laser
doppler velocimetry (Wieman et al., 1988) clearly demon-
strated the quantitative reduction in blood flow in normal
and neoplastic tissue after PDT, direct observation of the
microcirculation is required to determine the pathogenesis of
the vascular changes. Preliminary observations were reported
by Castellani et al. (1963) who described sequential changes
to the microcirculation in the frog tongue and rabbit
mesentery after treatment with haematoporphyrin and light.
The first detailed in vivo observations of the microcirc-
ulatory changes after HPD phototherapy were made using
sandwich observation chambers (Star et al., 1986). 'Blan-
ching' of the capillary bed in a rat mammary tumour was
observed during photoactivation. followed by a reduction in
the red blood cell column diameter (RBCCD) in larger
vessels. Capillary perfusion eventually returned unless high
light doses (> 70 J cm--) were used. This resulted in obvious
tumour necrosis 1-2 days after phototherapy. Significantly,
tumour regrowth occurred unless the circulation in a margin
of normal tissue adjacent to the tumour was also destroyed.
Normal tissue vessels were more resistant but eventually
underwent similar changes when higher light doses were used.
with apparent vasoconstriction (reduction in RBCCD).
platelet thrombosis, oscillatory and even reversed flow being
observed.
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The rat cremaster preparation has been used to study the
mechanism of action of PDT, in particular the sequence of
microcirculatory changes occurring during and shortly after
photoactivation. Activation by either blue or green light
30 min after the intra-arterial injection of dihaematoporphy-
rim ether (DHE) results in a rapid reduction in both
arteriolar and venular diameter, an effect which is both light
and photosensitiser dose dependent. In conjunction with the
formation and embolisation of platelet thrombi this leads to
stasis in 80% of arterioles and 90% of venules, with reper-
fusion occurring in only 20% of arterioles at 2 h (Reed et al..
1988). Similar changes have been demonstrated in implanted
tumour vessels after DHE-mediated PDT. with vasoconstric-
tion predominating in arterioles and thrombosis in venules
(Reed et al., 1989a). Sequential changes observed with the
light or electron microscope include early margination of
neutrophils, platelet aggregation, mitochondrial degeneration.
damage to endothelial cells and both vascular and skeletal
myocytes (Chaudhuri et al., 1987; Tseng et al.. 1988, Reed et
al., 1989a). A progressive increase in venular permeability to
albumin occurs, resulting in interstitial oedema (Fingar et al.,
1992). The resultant reduction in blood flow, in particular
that demonstrated in the periphery of tumours. and the
consequent hypoxia is thought to be of great significance in
the aetiology of the necrosis seen after PDT (Reed et al.,
1 989b).
These cellular changes do not however explain the very
rapid initial microcirculatory responses observed following
light administration. Recent studies using the rat cremaster
suggest that vasoactive agents such as prostaglandins or
thromboxane may mediate the early response. since administ-
ration of cyclooxygenase inhibitors such as indomethacin,
acetyl salicylic acid and the specific thromboxane A, receptor
antagonist SQ29548 prevent the vascular stasis (Reed et al..
1989c, 1991; Fingar et al., 1990).
It is clear from the evidence presented above that vascular
damage plays a significant role in PDT. But this pheno-
menon is not unique to the 'classical' photosensitisers HPD
and DHE. Sensitive fluorescence microscopy of frozen sec-
tions taken after sensitisation with phthalocyanine has dem-
onstrated localisation of fluorescence to well-vascularised
areas of stroma in the rat colon (Barr et al.. 1988), rat
bladder (Pope et al., 1991a), and hamster pancreas (Chatlani
et al., 1992). Using a radioactive microsphere technique,
blood flow to transplantable bladder tumours has been
shown to be markedly reduced after treatment with chloro-
aluminium tetrasulphophthalocyanine and light (Selman et
al., 1986), indicating that HPD and phthalocyanines have
similar effects on the microvasculature.
In contrast, studies of the distribution of PpIX fluore-
scence suggest that ALA-induced, PpIX-mediated phototox-
icity may have a fundamentally different mode of action,
with direct cytotoxicity predominating over vascular effects.
The evidence for this hypothesis is based on studies of ALA-
induced, PpIX fluorescence detected by sensitive fluorescence
microscopy of thin frozen sections. PpIX fluorescence in
hollow organs including colon, bladder and stomach has
been detected principally within cells, in contrast to the
perivascular distribution observed with phthalocyanines (Loh
et al., 1992, 1993; Bedwell et al., 1992). These findings have
led to the suggestion that ALA passes from the circulation
directly through the endothelial cells of capillaries, into the
extracellular fluid and diffuses into target cells, where it is
then converted to PpIX (Kennedy and Pottier, 1992). The
advantages suggested for this mode of action include:
(1) reduced likelihood of disruption to supporting tissue
and vascular stroma;
(2) improved healing with less scarring;
(3) selective eradication of small nests of tumour cells with-
out damage to adjacent normal tissue, provided diff-
erential photosensitisation exists between the two (Loh
et al.. 1993).
The results presented here clearly conflict with the
hypothesis derived from in vitro fluorescence distribution
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studies. ALA-induced, PpIX-mediated PDT has been shown
to have a profound effect on the microcirculation in these in
vivo studies. At the two higher power densities there was a
rapid power density-dependent reduction in arteriolar
RBCCD which reached a maximum at the end of the period
of photoactivation. Venular RBCCD was also affected but
the changes were quantitatively and qualitatively different.
Maximum reduction in venular diameter was less than that
demonstrated in equivalent order arterioles and the max-
imum effect occurred after the end of the period of photo-
activation. Changes in medium order vessel diameters were
accompanied by a reduction in flow in arterioles. venules and
capillaries. Complete or near complete stasis of capillary flow
was observed even at the end of the 2 h recovery period in
60% of the preparations receiving the two higher light doses,
suggesting that in many cases these microcirculatory changes
are irreversible.
The quantitative and qualitative changes in arteriolar and
venular RBCCD identified here are similar to those described
previously in this model using DHE as the photosensitiser.
The reported maximum reduction in arteriolar diameter in
the cremaster after activation of DHE with green light
(200 mW cm-'. 120 Jcm-2) is 20-40% of pretreatment
diameter. This occurs within the first 30 s of photoactivation.
reaching a maximum at 3 min. The reduction in venular
RBCCD is delaved compared with the arteriolar response
and reaches a maximum of 600/o of the pretreatment value
(Reed et al.. 1988). Using pooled data from the two higher
power density groups in this series (178 and 300 mW cm-')
the corresponding reductions with ALA were to 20% of
pretreatment value for the arterioles and 60% for the
venules. Reperfusion occurred by 2 h in 50% of the arterioles
and 25% of the venules in Reed's study using DHE (Reed et
al.. 1988). With ALA. reperfusion similarly occurred in 500/o
of arterioles bv 2 h. In contrast. after an initial reduction.
venous flow appeared to return to normal by the end of the
recovery period.
These findings strongly support recent evidence for a
microcirculatory effect from in vivo and ex vivo work. Using
an 'RbCI extraction method to compare blood flow in a rat
fibrosarcoma model. Roberts et al. (1994) have demonstrated
that phototherapy based on either polyhaematoporphyrin
(PHP) or ALA results in a significant reduction in tumour
vascular perfusion. Rapid initial reductions were observed (of
93% and 80% respectively). followed by partial recovery
over days. The pattern of change in both tumour vascular
perfusion and tumour growth was remarkably similar for
both agents. though recovery was more rapid after ALA-
induced PDT. Sandwich chamber observations using ALA-
induced PDT have demonstrated the rapid onset of microcir-
culatory damage in both normal rat skin and subcutaneously
implanted tumour tissue after photoactivation with green
light at I00 J cm 100mW cm--. The pattern of change in
severity of vascular damage was similar for skin and tumour.
reaching a maximum at the end of light activation (van der
Veen et al.. 1994). In contrast. we observed very little change
at this light dose and power density. This may be due to
differences in PpIX kinetics between the two tissues studied.
differences in the timing of light activation (60-100min is
240 min) or increased resistance of normal vessels to ALA-
induced PDT compared with tumour microvasculature. Fur-
ther evidence directly conflicting with the fluorescence micro-
scopy studies previously cited (Loh et al.. 1992. 1993;
Bedwell et al.. 1992) and corroborating the findings described
in this paper has been given by Roberts et al. (1994). Using
sensitive fluorescence microscopy in conjunction with the
Xvascular marker H33342. ALA-induced PpIX fluorescence
has been detected not only in the cytoplasm of tumour cells
but also in cells of the tumour vasculature. This latter obser-
vation being in keeping with the previously described correla-
tion between ALA-induced PpIX fluorescence and the loca-
tion of phototoxic damage (Divaris et al.. 1990).
In contrast to previous studies. we have examined the
effect of varying the rate of energy delivery (power density)
rather than total energy. At least in the case of ALA-
mediated PDT, the rate of light energy delivery may be as
significant a variable as the total energy used. Additionally
(at least in this particular model) there is a power density
threshold which must be exceeded for a significant PDT
effect to occur.
The mechanism of these microcirculatory changes was not
studied in detail in our experiments. but a number of obser-
vations may be made. Significant macromolecular leakage is
likely to be part of the response with ALA since interstitial
oedema was evident in the preparations even at the lowest
light dose. The question of whether the reduction in RBCCD
is due primarily to vasoconstriction or to platelet thrombosis
has not been addressed specifically and is the subject of
further studies. However. in a number of preparations
platelet thrombi were observed. in particular within venules.
The detachment and subsequent distal embolisation of these
thrombi occasionally resulted in reperfusion in the observed
vessel. This appeared to be independent of any obvious
change in vessel diameter. It does seem likely therefore that
in common with phototherapy using DHE. a combination of
vasoconstriction and thrombosis is responsible for the pro-
found changes in the microcirculation during ALA-induced.
PpIX-mediated PDT.
The significance of vascular changes in PDT is evident
from the studies carried out by other investigators and those
described above. But the microcirculation is to some extent a
non-specific' target and damage to it may be expected to
have deleterious effects in certain circumstances. This is
especially significant in the case of the urinary bladder. since
if photosensitiser concentration and or light dose within the
detrusor are not controlled, smooth muscle necrosis may
result from this microcirculatory damage. In clinical bladder
PDT this has been shown to lead to fibrous contracture of
the bladder and upper tract complications in some cases
(Harty et al.. 1989). Significantly an association has been
described between local vascularity and the extent of cellular
injury following PDT with HPD in transitional cell car-
cinoma (Schulock et al.. 1984). and in addition there is now
evidence that microcirculatory changes also occur in the
bladder after PDT (Reed et al., 1989d). In comparison with
the rat cremaster. studies of the urinary bladder micro-
circulation are sparse and the model is not as well developed.
However, similar microcirculatory changes to those in the
cremaster have been observed using electron microscopy,
with pavementing of leucocytes. platelet aggregation. eryth-
rocyte packing and endothelial cell damage. Detrusor
myocyte (smooth muscle) injury also occurs and is mainly
located near sites of severe vascular injury, suggesting a
significant relationship between these two events (Reed et al..
1989d; Tseng et al.. 1991).
This study has demonstrated that ALA-induced PDT has
profound effects on the normal microcirculation, including a
reduction in arteriolar and venular diameter, decreased blood
flow and capillary shutdown, which in some cases is non-
recoverable. These results suggest that microcirculatory
damage may contribute to the mechanism of action of
photodynamic therapy with ALA.
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